This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...